(Немає відомостей про примірники) Шифр: AM1/2007/99/4A Журнал 2007р. Vol. 99 N 4A Davidson, M. H. Introduction. / M.H. Davidson. - P.1B-2B Gotto, A. M. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus. / A.M. Gotto. - P.3B-5B Sameer, Bansilal. Role of insulin resistance and hyperglycemia in the development of atherosclerosis / Bansilal Sameer, M.E. Farkouh, V. Fuster. - P.6B-14B : il Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. - P.15B-26B : il Libby, P. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-a and peroxisome proliferator-activated receptor-y agonists. / P. Libby, J. Plutzky. - P.27B-40B : il Davidson, M. H. Global risk management in patients with type 2 diabetes mellitus. / M.H. Davidson. - P.41B-50B : il Uwaito, G. I. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk. / G.I. Uwaito, R.E. Ratner. - P.51B-67B : il Lee, M. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. / M. Lee, L.J. Aronne. - P.68B-79B : il Clair, LaDale St. Biological surrogates for enhansing cardiovascular risk prediction in type 2 diabetes mellitus. / LaDale St. Clair, C.M. Ballantyne. - P.80B-88B : il Feinstein, S. B. Diabetes mellitus and noninvasive imaging of atherosclerosis. / S.B. Feinstein. - P.89B-95B : il Rosenson, R. S. Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus. / R.S. Rosenson. - P.96B-104B : il Stone, K. E. Diabetic endovascular disease: role of coronary artery revascularization. / K.E. Stone, E. Chiquette, R.J. Chilton. - P.105B-112B : il Masoudi, F. A. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. / F.A. Masoudi, S.E. Inzucchi. - P.113B-132B : il Jones, P. H. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus. / P.H. Jones. - P.133B-140B : il Немає відомостей про примірники |
Risk for myopathy with statin therapy in high-risk patients [Text] / C.M. Ballantyne, A. Corsini, M.H. Davidson et al. // ARCHIVES of INTERNAL MEDICINE. - 2003. - Vol.163, N5. - P553-564 : табл. - Bibliogr.: 128 ref. . - ISSN 1072-4710 Рубрики: НЕЙРОПЕПТИДЫ--NEUROPEPTIDES МЫШЦЫ--MUSCLES Дод.точки доступу: Ballantyne, C.M.; Corsini, A.; Davidson, M.H.; Holdaas, H.; Jacobson, T.A. et al. Экз-ры: |
(Немає відомостей про примірники) Шифр: AM1/2007/100/11A Журнал 2007р. Vol. 100 N 11A Davidson, M. H. Introduction. / M.H. Davidson, P.P. Toth. - P.1N-2N : il Ansell, B. J. Targeting the anti-inflammatory effects of high-density lipoprotein. / B.J. Ansell. - P.3N-9N : il Orloff, D. G. Regulatory considerations in the development of high-density lipoprotein therapies. / D.G. Orloff. - P.10N-14N Rader, D. J. Liver X receptor and farnesoid X receptor as therapeutic targets. / D.J. Rader. - P.15N-19N : цв.ил Sprecher, D. L. Lipids, lipoproteins, and peroxisome proliferator activated reseptor-б. / D.L. Sprecher. - P.20N-24N. : il Schaefer, E. J. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. / E.J. Schaefer, B.F. Asztalos. - P.25N-31N : il Davidson, M. H. High-density lipoprotein matabolism: potential therapeutic targets. / M.H. Davidson, P.P. Toth. - P.32N-40N. : il Fruchart, J. -Ch. Novel Peroxisome proliferator activated receptor-a agonist. / J.-Ch. Fruchart. - P.41N-46N : цв.ил Kastelein, J. J.P. Refocusing on use of cholesteryl ester transfer protein inhibitors. / J.J.P. Kastelein. - P.47N-52N : цв.ил Kamanna, V. S. : Nicotinic acid (Niacin) Receptor agonists: will they be useful therapeutic agents? / V.S. Kamanna, M.L. Kashyap. - P.53N-61N : il Shah, P. K. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein. / P.K. Shah. - P.62N-67N : цв.ил Немає відомостей про примірники |
(Немає відомостей про примірники) Шифр: AM1/2007/100/11A Журнал 2007р. Vol. 100 N 11A Davidson, M. H. Introduction. / M.H. Davidson, P.P. Toth. - P.1N-2N : il Ansell, B. J. Targeting the anti-inflammatory effects of high-density lipoprotein. / B.J. Ansell. - P.3N-9N : il Orloff, D. G. Regulatory considerations in the development of high-density lipoprotein therapies. / D.G. Orloff. - P.10N-14N Rader, D. J. Liver X receptor and farnesoid X receptor as therapeutic targets. / D.J. Rader. - P.15N-19N : цв.ил Sprecher, D. L. Lipids, lipoproteins, and peroxisonne proliferator activated reseptor-б. / D.L. Sprecher. - P.20N-24N. : il Schaefer, E. J. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. / E.J. Schaefer, B.F. Asztalos. - P.25N-31N : il Davidson, M. H. High-density lipoprotein matabolism: potential therapeutic targets. / M.H. Davidson, P.P. Toth. - P.32N-40N. : il Fruchart, J. -Ch. Novel Peroxisome proliferator activated receptor-a agonist. / J.-Ch. Fruchart. - P.41N-46N : цв.ил Kastelein, J. J.P. Refocusing on use of cholesteryl ester transfer protein inhibitors. / J.J.P. Kastelein. - P.47N-52N : цв.ил Kamanna, V. S. : Nicotinic acid (Niacin) Receptor agonists: will they be useful therapeutic agents? / V.S. Kamanna, M.L. Kashyap. - P.53N-61N : il Shah, P. K. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein. / P.K. Shah. - P.62N-67N : цв.ил Немає відомостей про примірники |
Davidson, M. H. Introduction. [Text] / M.H. Davidson, P.P. Toth // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.100, N11A. - P1N-2N : il . - ISSN 0002-9149 Дод.точки доступу: Toth, P.P. Экз-ры: |
Davidson, M. H. High-density lipoprotein matabolism: potential therapeutic targets. [Text] / M.H. Davidson, P.P. Toth // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.100, N11A. - P32N-40N. : il. - Ref. : p. 39N-40N. . - ISSN 0002-9149 Рубрики: ЛИПОПРОТЕИНЫ ВЫСОКОЙ ПЛОТНОСТИ--LIPOPROTEINS, HDL Дод.точки доступу: Toth, P.P. Экз-ры: |
Davidson, M. H. Introduction. [Text] / M.H. Davidson // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.99, N4A. - P1B-2B . - ISSN 0002-9149 Рубрики: ДИАБЕТ САХАРНЫЙ--DIABETES MELLITUS Экз-ры: |
Davidson, M. H. Global risk management in patients with type 2 diabetes mellitus. [Text] / M.H. Davidson // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.99, N4A. - P41B-50B : il. - Ref. : p. 48B-50B . - ISSN 0002-9149 Рубрики: ДИАБЕТ САХАРНЫЙ--DIABETES MELLITUS Экз-ры: |
Safety considerations with fibrate therapy [Text] / M.H. Davidson, A. Armani, J.M. McKenney, T.A. Jacobson // AMERICAN JOURNAL of CARDIOLOGY. - 2007. - Vol.99, NSuppl.6. - 3C-18C : il. - Ref. : p. 15C-18C . - ISSN 0002-9149 Рубрики: ДИСЛИПИДЕМИЯ--DYSLIPIDEMIAS Дод.точки доступу: Davidson, M.H.; Armani, A.; McKenney, J.M.; Jacobson, T.A. Экз-ры: |